{
    "id": 28864,
    "fullName": "FGR over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "FGR over exp indicates an over expression of the Fgr protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 2268,
        "geneSymbol": "FGR",
        "terms": [
            "FGR",
            "c-fgr",
            "c-src2",
            "p55-Fgr",
            "p55c-fgr",
            "p58-Fgr",
            "p58c-fgr",
            "SRC2"
        ]
    },
    "variant": "over exp",
    "createDate": "10/24/2018",
    "updateDate": "10/24/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 15114,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, B-cell lymphoma cell lines with high expression of FGR were resistant to Zolinza (vorinostat) in culture (PMID: 27324824).",
            "molecularProfile": {
                "id": 30753,
                "profileName": "FGR over exp"
            },
            "therapy": {
                "id": 1077,
                "therapyName": "Vorinostat",
                "synonyms": null
            },
            "indication": {
                "id": 707,
                "name": "B-cell lymphoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 12669,
                    "pubMedId": 27324824,
                    "title": "A novel approach to detect resistance mechanisms reveals FGR as a factor mediating HDAC inhibitor SAHA resistance in B-cell lymphoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27324824"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 30753,
            "profileName": "FGR over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}